NCT07222007 Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
| NCT ID | NCT07222007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zeliha Alicikus |
| Condition | Critically Ill |
| Study Type | OBSERVATIONAL |
| Enrollment | 4 participants |
| Start Date | 2026-04-18 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4 participants in total. It began in 2026-04-18 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this retrospective cohort study is to compare the safety and efficacy of induction agents for tracheal intubation in critically ill adult patients.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Admission to the surgical ICU for critical care * Administration of one of the studied induction agents * Availability of complete clinical data Exclusion Criteria: * Age \< 18 years * Absence of documented induction agent administration * Incomplete or missing medical records
Contact & Investigator
TOLGA SARAÇOĞLU, Prof,MD
PRINCIPAL INVESTIGATOR
Florida University Jacksonville
Frequently Asked Questions
Who can join the NCT07222007 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Critically Ill. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07222007 currently recruiting?
Yes, NCT07222007 is actively recruiting participants. Contact the research team at kemaltolgasaracoglu@gmail.com for enrollment information.
Where is the NCT07222007 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT07222007 clinical trial?
NCT07222007 is sponsored by Zeliha Alicikus. The principal investigator is TOLGA SARAÇOĞLU, Prof,MD at Florida University Jacksonville. The trial plans to enroll 4 participants.